3rd Quarter - Report — CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION (2010)

Firm

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Client

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Income

—

Expenses

$736,734

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

Lobbyist	Covered position, as disclosed
ANDREW FISH	—
TRAVIS GIBBONS New	Office of Senator Orrin G. Hatch
ALLEN SEGAL	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA)

Bills named: H.R. 1259 (111th), H.R. 2923 (111th)

Law Enforcement/Crime/Criminal Justice LAW

HR 5932 - regarding organized retail crime

Lobbyist	Covered position, as disclosed
TRAVIS GIBBONS New	Office of Senator Orrin G. Hatch
ALLEN SEGAL	—

Contacted: Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); SENATE; Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5932 (111th)

Pharmacy PHA

Issues related to methamphetamine precursor chemicals HR 759, HR 5740, S 882, S 3690 - regarding the manufacturing and importation of OTC drugs and the mandatory recall authority of the FDA.

Lobbyist	Covered position, as disclosed
ANDREW FISH	—
TRAVIS GIBBONS New	Office of Senator Orrin G. Hatch
ALLEN SEGAL	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Internal Revenue Service (IRS)

Bills named: H.R. 5740 (111th), H.R. 759 (111th)

Taxation/Internal Revenue Code TAX

Final IRS guidance on provision of Patient Protection and Affordable Care Act (P.L. 111-148, P.L. 111-152) prohibiting use of flexible spending account (FSA) and health savings account (HSA) funds on over-the-counter medications.

Lobbyist	Covered position, as disclosed
TRAVIS GIBBONS New	Office of Senator Orrin G. Hatch
ALLEN SEGAL	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP)

Food Industry (safety, labeling, etc.) FOO

HR 2749, S 510, S 3002, S 3414 - regarding the manufacturing and regulation of nutritional supplements

Lobbyist	Covered position, as disclosed
ANDREW FISH	—
TRAVIS GIBBONS New	Office of Senator Orrin G. Hatch
ALLEN SEGAL	—

Contacted: Internal Revenue Service (IRS); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2749 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.